Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Dealing with the FDA – The Pharma Experience Uwe P. Trinks, Ph.D TMA Annual Meeting, Williamsburg, VA Agenda The World of FDA Code of Federal Regulations Drug Development and Approval GLP, GCP, GMP Computerized Systems Validation 21 CFR Part 11 Systems Development Life Cycle Management Change Control Risk Management Pre- and Post-marketing Safety FDAAA REMS and RiskMAP What now? Tobacco Merchants Association, Williamsburg, VA Federal Regulations In the beginning, there was chaos… Then someone created the regulations… And made things worse! Tobacco Merchants Association, Williamsburg, VA US Code of Federal Regulations 50 Titles (Books) Title 21: Food and Drugs Clinical Trials: Part 50, GLP: Part 58 GMP: Part 210 et al. Drug Safety: 21 CFR Parts 310, 312, 314, 320, 600, 601, and 606 Devices: 21 CFR Part 803 Quality: 21 CFR Part 820 Electronic Signatures: 21 CFR Part 11 HIPAA: 45 CFR Part 160 - 164 Tobacco Merchants Association, Williamsburg, VA Current Pharmaceutical Development Process Phase 1 12-18 months Poor understanding of disease and lack of predictive capabilities Phase 2a Phase 2b 15 months 18 months Decision points often rate limiting Ethical concerns regarding placebo controlled trials Phase 3 35 months High late stage attrition Commercial Efficacy Patient ‘wastage’ in dose ranging trials High attrition – large number of NME’s needed Safety ensures it is not a “rat poison” Minimal Safety Tobacco Merchants Association, Williamsburg, VA “Reasonable” Safety established in majority of population Registration 12-18 months Patients exposed to non-efficacous drugs (> 50%) Side effects and drug interactions emerge postlaunch FDA Motto “In God we trust, all others need to bring data” Tobacco Merchants Association, Williamsburg, VA GxP GLP GMP GCP IND Drug Discovery Preclinical Research Preclinical Development ADME, Tox TRD Tobacco Merchants Association, Williamsburg, VA NDA Approval Clinical Development Ph 0 Ph I Ph II Ph III Ph IV GxP Good Laboratory Practices (Part 58) Animal Handling, Lab Test, Laboratory Notebooks, SOPs etc. Good Manufacturing Practices (Part 210, 211) Process, Shop Floor Control, Manufacturing, QC, QA, Handling and Shipping, SOPs etc. Quality Mgmt System (Part 820) Good Clinical Practices (Part 310, 312, 314) Protocols, Trial Design, Trial Site Monitoring, Statistics, QC, QA, Clinical data Management, SOPs etc. Computerized Systems Validation (Part 11) Predicate Rules: GCP/GLP/GMP (GxP) FDA Guidances Industry Guidance G@MP Tobacco Merchants Association, Williamsburg, VA Computerized Systems Validation Definition Establishing documented evidence which provides a high degree of assurance that a computerized system will consistently perform according to predetermined specifications and quality attributes FDA’s cGMP for the 21st Century Risk based approach to CSV Tailored Validation Approach 21 CFR Part 11 Electronic signatures “Mother of all laws” for CSV 45 CFR Part 160-164 (HIPAA) Privacy Rule 160 Security Rule 162 –164 IT best practices document FDA Guidance Documents Electronic Signatures (2003) Computerized Systems in Clinical Trials (1999) General Principles of Software Validation (2002) Tobacco Merchants Association, Williamsburg, VA 21 CFR Part 11 Guidance Supersedes all old Guidance Documents Contains detailed Recommendations on Study Protocol SOPs Source Documents and Retention Internal and External Security Safeguards System Features such as Tobacco Merchants Association, Williamsburg, VA Data Entry and Retrieval Systems Documentation Systems Controls Change Control Training of Personnel Validation Process Application Validation Governing SOPs and Policies Tobacco Merchants Association, Williamsburg, VA Layered Software Operational Qualification Hardware/OS Installation Qualification Why Validate ? It’s good business practice FDA’s reaction to non-compliance Form 483 FDA form, used to report inspectoral observations Usually combined with timelines to fix the problems Addressed to Top-Management Usually results in another inspection Warning Letter Published letter by the FDA Reports that a company has not satisfactory corrected problems previously cited in a 483 Usually combined with a threat of action Extremely damaging to a company’s reputation Tobacco Merchants Association, Williamsburg, VA Systems Development Lifecycle An approach to computer system development that begins with identification of the user's requirements; continues through design, integration, qualification, validation, control, and maintenance; and ends only when commercial use of the system is discontinued. Tobacco Merchants Association, Williamsburg, VA Systems Development Lifecycle Archiving Mandate Risk Assessment User Requirements Systems Decommission Change Management Systems Release Documentation Training Buy - Build Technical Specifications Validation Plan (Protocol) Validation Report IQ, OQ, PQ Programming PQ Scripts Tobacco Merchants Association, Williamsburg, VA Traceability Matrix Systems Test Risk Management Tobacco Merchants Association, Williamsburg, VA Risk - Benefit Benefit poorly understood Efficacy ≠ Benefit Risk hard to quantify Even harder to disproof Risk Benefit Management is the constant measure, assessment, mitigation and communication of risk against demonstrable benefit Based on a solid, scientifically sound platform for data collection and processing Tobacco Merchants Association, Williamsburg, VA FDAAA 2007 Title I – Prescription Drug User Fee Amendments Title II – Medical Device User Fee Amendments Title III – Pediatric Medical Device Safety and Improvement Act Title IV – Pediatric Research Equity Act Title V – Best Pharmaceuticals for Children Act Title VI – Reagan-Udall Foundation Title VII – Conflicts of Interest Title VIII – Clinical Trial Database Title IX – Enhanced Authorities Regarding Post-market Safety of Drugs Title X – Food Safety Title XI – Other Provisions Tobacco Merchants Association, Williamsburg, VA Pharmacovigilance Adverse Events from all Sources Adverse Event Assessment & Data Entry Expedited Safety Reports Risk Management Planning Safety Database Benefit-Risk Balance Assessment Signal Detection/ Query Handling Reports Tobacco Merchants Association, Williamsburg, VA Expert Review PSURs Signal Evaluation Actions Epidemiological Studies Clinical Development The three I’s of Safety Intake Investigation QC of Intake Coding, Assessment Narrative Active Query Generation Integrity QC of Investigation Company Assessment Causality Query Approval Intake Metrics and Case Management Complete data Entry Auto-coding, Auto-Narrative Attach Source QC Investigation QC Integrity QC Reporting File Tobacco Merchants Association, Williamsburg, VA Revisions Safety System Costs - Implementation Config & Validation 20% Vendor Audit 2% Project Mgmt 17% SOP 6% HW 15% Installation 12% SW 28% Implementation: $ 0.5 -1.5 Mio Tobacco Merchants Association, Williamsburg, VA Safety System Costs - Operations MedDRA Upgrade 13% OS and DB Upgrade 41% WHODrug Upgrade 3% Software Maintenance 15% Operations and Support 28% Annual Operation: $ 0.4 - 1.2 Mio Tobacco Merchants Association, Williamsburg, VA Pharmaceutical Safety Department • Expedited Safety Reports (7 day, 15 day) • Periodic Reports (Quarterly – Annually) • Risk Evaluation and Mitigation Systems Head of Safety Clinical Safety • Safety issue and signal identification • Safety / risk management / monitoring plans Case Mgmt & Operations • Case processing and submission for Adverse Event reports Tobacco Merchants Association, Williamsburg, VA Systems • Maintenance of safety database and supporting applications • Signal detection support • Query support Support • • • • Training QA Compliance Process Mgmt and Control • Standards • Project Mgmt • Affiliate Control Medical Surveill & Epi • • • • Aggregate Reports Safety Summaries Queries Epidemiological Analyses • Medical Review of cases • Signal Identification and Analysis Components of Risk Management Plans Safety Specifications Summary of important identified risks, important potential risks and missing Information (ICH E2E) Pharmacovigilance Plan Based on Safety Specifications: Routine PV practices and Action plan to investigate specific safety concerns (ICH E2E) Risk Minimization REMS Activities to be taken to minimize the impact of specific safety concerns on the Benefit-Risk balance Tobacco Merchants Association, Williamsburg, VA Risk Evaluation and Minimization (REMS) Communication plan to Health Care Professionals Medication guide or patient package insert Patient registries HCP education/certification Restricted distribution programs Limitations on HCP who may administer the drug Patient certification Limitations on the patients who may use the drug Linked prescribing/dispensing to lab tests Regular measurements of effectiveness (1.5, 3, 7 years) Failure to comply Penalties from $ 250,000 to $ 1,000,000 per incident After warning $ 250,000 per 30 days, doubling every 30 days up to $ 10,000,000 per single incident Tobacco Merchants Association, Williamsburg, VA The new Safety Data Collection Patients Collect Demographics and Basic Data Drug correctly administered and well tolerated Collect additionally Patient History and Health Records Known Problem Known Cause Additionally request (and pay for) Lab Tests, Collect DNA (if consent) Unknown Serious Additionally enroll Patient in Follow-up Monitoring Program. Change Treatment Related Collect everything possible, especially Autopsy Reports, Issue Warnings Death Tobacco Merchants Association, Williamsburg, VA What now? “You cannot tailor-make the situations in life, but you can tailor-make the attitudes to fit those situations” Zig Ziglar Tobacco Merchants Association, Williamsburg, VA utrinks@foresight-grp.com Tobacco Merchants Association, Williamsburg, VA